Secukinumab dosing every two weeks demonstrated superior efficacy compared with dosing every four weeks in patients with psoriasis weighing 90 kg or more: Results of a randomised controlled trial
Keyword(s):
2006 ◽
Vol 2006
◽
pp. 116-117
Keyword(s):
2008 ◽
Vol 2008
◽
pp. 237-238
2007 ◽
Vol 2007
◽
pp. 51-53